Synergistic Systems for Enhanced Fluid Balance Monitoring and Control

Publication ID: 24-11857714_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Systems for Enhanced Fluid Balance Monitoring and Control,” Published Technical Disclosure No. 24-11857714_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857714_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,714.

Summary of the Inventive Concept

The present inventive concept integrates AI, IoT, blockchain, and new materials with biological fluid processing devices to create a more powerful system for monitoring and controlling fluid balance during medical procedures, enhancing patient safety and treatment outcomes.

Background and Problem Solved

The original patent disclosed systems and methods for monitoring and controlling fluid balance in medical procedures, but it had limitations in terms of real-time data analysis, patient data security, and fluid flow efficiency. The new inventive concept addresses these limitations by incorporating advanced technologies to provide a more comprehensive and effective solution.

Detailed Description of the Inventive Concept

The new system comprises a fluid circuit, a separation chamber, a treatment container, and an AI-powered controller that predicts and prevents fluid imbalances based on real-time data from IoT-enabled sensors. Additionally, the system integrates blockchain technology to securely store and track patient data and treatment protocols. The biological fluid processing device features a new material-based fluid conduit that enhances fluid flow and reduces contamination risk. The system also utilizes machine learning algorithms to analyze data from multiple sources and identify high-risk patients, optimizing treatment protocols.

Novelty and Inventive Step

The new claims introduce the novel combination of AI, IoT, blockchain, and new materials with biological fluid processing devices, providing a synergistic effect that enhances the overall system's performance and safety. The inventive step lies in the integration of these distinct technologies to create a more powerful and effective system for monitoring and controlling fluid balance.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different AI algorithms, IoT sensor configurations, or blockchain platforms. Variations may also include the integration of additional technologies, such as robotic automation or virtual reality, to further enhance the system's capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of blood processing, dialysis, and surgical procedures. The system's enhanced safety and efficiency features make it an attractive solution for hospitals, clinics, and medical research institutions.

CPC Classifications

SectionClassGroup
A A61 A61M1/3607
A A61 A61M1/0209
A A61 A61M1/361
A A61 A61M1/3643
A A61 A61M1/3672
A A61 A61M1/3683
A A61 A61M1/3693
A A61 A61M1/3696
A A61 A61M1/38
A A61 A61M2202/0092
A A61 A61M2202/0407
A A61 A61M2202/0413
A A61 A61M2202/0415
A A61 A61M2202/0429
A A61 A61M2202/0439
A A61 A61M2202/0443
A A61 A61M2205/3386
A A61 A61M2205/50
A A61 A61M2230/005
A A61 A61M2230/207

Original Patent Information

Patent NumberUS 11,857,714
TitleSystems and methods for monitoring and controlling fluid balance during a biological fluid procedure
Assignee(s)Fenwal, Inc.